ProfileGDS4718 / 220397_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 22% 18% 80% 25% 26% 52% 44% 22% 25% 32% 31% 16% 36% 49% 41% 32% 38% 46% 54% 27% 22% 33% 37% 28% 29% 34% 24% 38% 26% 33% 43% 42% 22% 27% 40% 60% 35% 24% 20% 78% 33% 34% 45% 47% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.2475622
GSM549102patient 115, normal, homogenized [OPG study]4.0675218
GSM549104patient 119, normal, homogenized [OPG study]7.8773980
GSM549108patient 138, normal, homogenized [OPG study]4.3864925
GSM549119patient 077, normal, homogenized [OPG study]4.373626
GSM549133patient 032, cancer, homogenized [OPG study]5.5683752
GSM549139patient 042, cancer, homogenized [OPG study]5.1602144
GSM549099patient 107, normal, homogenized [OPG study]4.2536622
GSM549109patient 139, normal, homogenized [OPG study]4.379825
GSM549110patient 046, normal, homogenized [OPG study]4.6180132
GSM549114patient 063, normal, homogenized [OPG study]4.5501631
GSM549122patient 082, normal, homogenized [OPG study]4.0191916
GSM549134patient 033, cancer, homogenized [OPG study]4.7940236
GSM549136patient 036, cancer, homogenized [OPG study]5.4097849
GSM549140patient 044, cancer, homogenized [OPG study]4.9963741
GSM549111patient 047, normal, homogenized [OPG study]4.6117332
GSM549113patient 057, normal, homogenized [OPG study]4.8416238
GSM549132patient 031, cancer, homogenized [OPG study]5.3116246
GSM549137patient 038, cancer, homogenized [OPG study]5.7652454
GSM549142patient 047, cancer, homogenized [OPG study]4.5207327
GSM549100patient 110, normal, homogenized [OPG study]4.2263822
GSM549107patient 135, normal, homogenized [OPG study]4.6255333
GSM549115patient 068, normal, homogenized [OPG study]4.7848937
GSM549116patient 072, normal, homogenized [OPG study]4.4242628
GSM549120patient 078, normal, homogenized [OPG study]4.4833929
GSM549131patient 030, cancer, homogenized [OPG study]4.6508534
GSM549118patient 074, normal, homogenized [OPG study]4.3085624
GSM549129patient 027, cancer, homogenized [OPG study]4.9234138
GSM549123patient 088, normal, homogenized [OPG study]4.3632726
GSM549124patient 006, cancer, homogenized [OPG study]4.7059133
GSM549126patient 015, cancer, homogenized [OPG study]5.1413443
GSM549128patient 025, cancer, homogenized [OPG study]5.0617642
GSM549103patient 117, normal, homogenized [OPG study]4.2800322
GSM549117patient 073, normal, homogenized [OPG study]4.3850627
GSM549138patient 041, cancer, homogenized [OPG study]4.9660240
GSM549141patient 045, cancer, homogenized [OPG study]6.1574960
GSM549130patient 028, cancer, homogenized [OPG study]4.7849435
GSM549101patient 111, normal, homogenized [OPG study]4.3111624
GSM549105patient 128, normal, homogenized [OPG study]4.1638520
GSM549106patient 134, normal, homogenized [OPG study]7.7940278
GSM549112patient 048, normal, homogenized [OPG study]4.6758933
GSM549125patient 011, cancer, homogenized [OPG study]4.7318434
GSM549127patient 024, cancer, homogenized [OPG study]5.2272145
GSM549135patient 035, cancer, homogenized [OPG study]5.325347